Boston Scientific Corp
(BSP:B1SX34)
R$
575.92
+8.57 (+1.51%)
Market Cap: 851.83 Bil
Enterprise Value: 914.11 Bil
PE Ratio: 73.82
PB Ratio: 6.85
GF Score: 66/100 Boston Scientific Corp at Stifel Healthcare Conference Transcript
Nov 15, 2022 / 01:00PM GMT
Release Date Price:
R$226.38
Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst
Good morning, everybody. It's a pleasure to see you all. Thank you for joining us here in the room and online. It is my great pleasure, and it's sincere pleasure to welcome 2 outstanding members of the Boston Scientific team. Dan Brennan, to my left, Chief Financial Officer and Executive Vice President; and Lauren Tengler, Head of Investor Relations, to open up this year's health care conference. Thank you both for being here. And Dan, I don't know whether to offer congratulations or condolences. This is -- we're celebrating our 10th year together here, you know?
Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO
Excited. Excited to be here. Thanks again for the invitation. It's always a pleasure to be here with you.
Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst
And we're grateful and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
